Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,095.45
-24.25 (-2.17%)
At close: Jul 30, 2026
Alivus Life Sciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 25,904 | 25,518 | 23,869 | 22,832 | 21,612 | 21,232 |
Revenue Growth | 7.93% | 6.91% | 4.54% | 5.64% | 1.79% | 12.63% |
Gross Profit Gross Profit Growth | 15,392 | 14,853 | 12,561 | 12,433 | 11,144 | 10,555 |
Operating Income Operating Income Growth | 7,578 | 7,219 | 6,238 | 6,221 | 6,008 | 5,789 |
Net Income Net Income Growth | 6,030 | 5,645 | 4,856 | 4,709 | 4,670 | 4,187 |
Earnings Per Share EPS Growth | 49.03 | 45.90 | 39.52 | 38.38 | 38.11 | 35.63 |
EPS Growth | 21.61% | 16.14% | 2.97% | 0.71% | 6.97% | 9.26% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 11,524 | 11,665 | 11,330 | 11,519 |
outside India outside India Growth | 12,345 | 11,167 | 10,282 | 9,713 |
Total Total Growth | 23,869 | 22,832 | 21,612 | 21,232 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 7,825 | 7,825 | 5,487 | 3,014 | 2,838 | 5,123 |
Total Debt Total Debt Growth | 567.71 | 567.71 | 566.06 | 171.48 | 193.57 | 28.84 |
Net Cash (Debt) Net Cash Growth | 7,257 | 7,257 | 4,921 | 2,843 | 2,645 | 5,094 |
Net Cash Growth | 47.44% | 47.49% | 73.10% | 7.49% | -48.08% | - |
Net Cash Per Share Net Cash Per Share Growth | 59.01 | 59.01 | 40.04 | 23.17 | 21.58 | 43.34 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 5,654 | 3,915 | 4,135 | 3,060 | 5,976 |
Capital Expenditures CapEx Growth | - | -3,071 | -1,662 | -1,290 | -1,628 | -1,322 |
Free Cash Flow Free Cash Flow Growth | - | 2,584 | 2,253 | 2,845 | 1,432 | 4,654 |
Free Cash Flow Growth | - | 14.65% | -20.81% | 98.69% | -69.23% | 45.39% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 59.42% | 58.20% | 52.63% | 54.45% | 51.56% | 49.71% |
Operating Margin | 29.25% | 28.29% | 26.13% | 27.25% | 27.80% | 27.27% |
Pretax Margin | 30.90% | 29.44% | 27.41% | 27.65% | 29.09% | 26.61% |
Profit Margin | 23.28% | 22.12% | 20.35% | 20.62% | 21.61% | 19.72% |
FCF Margin | - | 10.12% | 9.44% | 12.46% | 6.63% | 21.92% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 5.000 | 22.500 | 21.000 | 21.000 |
Dividend Per Share Growth | 0% | 0% | -77.78% | 7.14% | 0% | - |
Dividend Yield | 0.46% | 0.51% | 0.47% | 2.92% | 5.58% | 5.14% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.61 | 21.15 | 27.28 | 20.21 | 10.31 | 13.43 |
P/FCF Ratio | 55.11 | 46.21 | 58.79 | 33.44 | 33.62 | 12.08 |
PS Ratio | 5.50 | 4.68 | 5.55 | 4.17 | 2.23 | 2.65 |